SCHEMBL7789686

SCHEMBL7789686

COC(=O)C(C1CC=CCC1)C(NC(=O)OCc1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 15/20 0.47
▸ TSHR P16473 11/20 0.47
▸ ALDH1A1 P00352 6/20 0.47
▸ CYP2C9 P11712 4/20 0.47
▸ CYP2C19 P33261 4/20 0.47
▸ CYP1A2 P05177 4/20 0.47
▸ POLB P06746 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ LMNA P02545 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ CASP1 P29466 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9204853 0.84 CYP3A4 (0.48) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL6349369 0.75 ATM (0.54) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL12068190 0.75 ATM (0.54) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL6351946 0.75 ATM (0.54) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL15312885 0.75 ATM (0.54) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL3331779 0.73 ATM (0.55) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL8295707 0.73 ATM (0.57) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL13168629 0.73 CYP3A4 (0.67) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL7793054 0.72 NPC1 (0.39) CYP3A4TSHRALDH1A1CYP2C9CYP2C19
SCHEMBL7277348 0.71 CYP3A4 (0.43) CYP3A4TSHRALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0641328-B1 BRIDGED AZA-BICYCLIC DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER (US) 2001-11-21 — — EP disclosed
US-5498614-A Bridged aza-bicyclic derivatives as substance P antagonist PFIZER INC. (US) 1996-03-12 — — US disclosed
EP-0641328-A1 BRIDGED AZA-BICYCLIC DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1995-03-08 — — EP disclosed
WO-1993023380-A1 BRIDGED AZA-BICYCLIC DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1993-11-25 — — WO disclosed
Send feedback